Contact
Please use this form to send email to PR contact of this press release:
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Reata Pharmaceuticals, Inc. Investors of Important December 14 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – RETA
TO: